GlaxoSmithKline has supported the Cancer Research Institute across patient education and thought leadership, providing sponsorship for the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, inaugural Immunotherapy Patient Summit, and multi-year sponsorship of the Immunotherapy Patient Summit series. In addition, GSK has provided unrestricted support to advance the Cancer Research Institute mission.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
July is Sarcoma Awareness Month. As a rare and difficult-to-treat form of cancer, effective drug treatments are urgently needed and immunotherapy for sarcoma shows promise.
Dr. Joan Levy, director of research at the Chordoma Foundation, discusses the current state of chordoma research and the recently launched partnership with CRI.